Clinical Trials

The protection of personal data is of high importance to Genmab and Genmab is committed to safeguard study subjects’ rights when Genmab handles their personal data as a sponsor of clinical trials.

Genmab is required to provide patients with sufficient and clear information about Genmab’s use of their personal data collected during their participation in the Genmab clinical trials in order to ensure transparency about how Genmab handles personal data collected for the study purpose and to properly inform study subjects of their rights towards Genmab.

On this page we’ll provide you with information on how Genmab processes study subjects’ personal data when participating in a specific Genmab clinical trial. Please see the menu below.

Clinical Trial Privacy Policies
GCT1015-04 – International Trial of Tisotumab Vedotin (HuMax®-TF-ADC)Read
GCT1015-05 – International Trial of Tisotumab Vedotin (HuMax®-TF-ADC)Read
GCT3013-03 – Trial of Epcoritamab (GEN3013; DuoBody®-CD3 X CD20)Read
GCT3017-01 – International Trial of DuoBody®-CD3xCD30Read

You are now leaving to go to our collaborator’s website. If you continue, we encourage you to read the website’s privacy and cookie policy.